Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc.（NVCT）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
nvct · 股价预测 · 2 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 2 位华尔街分析师
Buy
2 位分析师
共识
评级分布
12 个月目标价
High
$10.00
Consensus
$10.00
+6.2% upside
Low
$10.00
Median: $10 · Last Close: $9.42
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $8.95 | ↓ 5.00% |
1-day model range: $8.87–$9.03. Peak: $9.03 (-5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $10 | +2.0% |
| 2028 | $10 | +3.0% |
| 2029 | $10 | +3.6% |
| 2030 | $10 | +3.8% |
| 2031 | — | +4.0% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · NVCT · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-08-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-30 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-02-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-08 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-09-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-03-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-02-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2022-07-13 | Ladenburg Thalmann | Maintains | Buy→Buy |
| 2022-05-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Nuvectis Pharma, Inc. (NVCT) stock. Of the recent 11 rating actions, 0 were upgrades and 0 were downgrades. 2 analysts currently cover NVCT.
分析师推荐趋势
NVCT analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$3M
↓ 74.2% YoY
Revenue Next Year
$26M
↑ 779.6% YoY
EPS This Year
$-1.05
EPS Next Year
$-1.07
↑ 2.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast NVCT EPS of $-1.05 for the current fiscal year, based on estimates from 4 analysts. The NVCT revenue forecast is $3M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
NVCT 股价预测由两类独立数据源支撑：来自 2 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。NVCT 的共识目标价为 $10.00（+6.2% 上行空间），分析师共识为 Buy。
NVCT 的短期预测（明日）为 $8.95（-5.00%）。 NVCT 对 2027 年的股价预测均值为 $10。 NVCT 对 2030 年的预测区间为 $9–$11。
Nuvectis Pharma, Inc. 在 NASDAQ 上市，代码 NVCT。NVCT 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
NVCT 预测 · 8 个问题根据 2 位华尔街分析师，NVCT 的 12 个月平均目标价为 $10.00，最高 $10.00、最低 $10.00。若有图表，中位目标价可在上方查看。相对当前价 $9.42，隐含约 +6.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.